Abstract
Biochemical, behavioral, and electrophysiologic studies indicate that activation of the noradrenergic cells in the locus coeruleus (LC) plays an important role in the symptoms of opiate withdrawal. Extrinsic factors play a major role in the morphine-withdrawal-induced activation of the LC, but intrinsic factors also play a role. Among the extrinsic factors, a glutamatergic projection from the nucleus paragigantocellularis plays an important role in the withdrawal-induced activation of the LC.
N-methyl-D-aspartic acid (NMDA) receptors play at most a minor role in the withdrawal-induced activation of the LC by glutamate; preliminary evidence indicates that α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors play an important role. Whereas NMDA antagonists produce little to no suppression of the activation of the LC during morphine withdrawal, they do suppress many morphine withdrawal symptoms. However, phencyclidinelike side effects may limit the clinical utility of NMDA antagonists. Experiments examining c-fos expression during morphine withdrawal indicate that NMDA antagonists may exert some of their influence on morphine withdrawal symptoms through actions in the forebrain. Pretreatment with the noncompetitive NMDA antagonist MK801 blocks morphine withdrawal-induced increased c-fos expression in the amygdala, but not in the nucleus accumbens, frontal cortex, or hippocampus. Pretreatment with the competitive NMDA antagonist LY274614 (or the α2-adrenergic agonist clonidine) blocks morphine withdrawal-induced increased c-fos expression in the amygdala and nucleus accumbens, but not in the frontal cortex or hippocampus. These results help to elucidate some of the neuroanatomy and neurophysiology underlying morphine withdrawal. Further, NMDA antagonists may not be clinically useful for opiate withdrawal due to their side-effects, but AMPA antagonists may be of great benefit for alleviating opiate withdrawal symptoms in humans.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rasmussen, K. The Role of the Locus Coeruleus and N-Methyl-D-Aspartic Acid (NMDA) and AMPA Receptors in Opiate Withdrawal. Neuropsychopharmacol 13, 295–300 (1995). https://doi.org/10.1016/0893-133X(95)00082-O
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/0893-133X(95)00082-O
Keywords
This article is cited by
-
Mu opioid receptors in the medial habenula contribute to naloxone aversion
Neuropsychopharmacology (2020)
-
Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice
Scientific Reports (2018)
-
Role of low-intensity laser therapy on naloxone-precipitated morphine withdrawal signs in mice: is nitric oxide a possible candidate mediator?
Lasers in Medical Science (2014)
-
Distinct Profiles of Anxiety and Dysphoria during Spontaneous Withdrawal from Acute Morphine Exposure
Neuropsychopharmacology (2009)
-
Morphine Tolerance and Reward but not Expression of Morphine Dependence are Inhibited by the Selective Glutamate Carboxypeptidase II (GCP II, NAALADase) Inhibitor, 2-PMPA
Neuropsychopharmacology (2003)